Markers of Hemophagocytic Lymphohistiocytosis Are Associated with Mortality in Critically Ill Patients
Authors:
- Max LenzMax Lenz
- Patrick HaiderPHPatrick Haider
- Eva SteinacherEva Steinacher
- Constantin GattererCGConstantin Gatterer
- Robert ZilberszacRobert Zilberszac
- Svitlana DemyanetsSDSvitlana Demyanets
- Christian HengstenbergCHChristian Hengstenberg
- Johann WojtaJWJohann Wojta
- Gottfried HeinzGHGottfried Heinz
- Walter S. SpeidlWSWalter S. Speidl
- Konstantin A. KrychtiukKKKonstantin A. Krychtiuk
Open Access
- 14 March 2025
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (6) , 1970
Abstract
Background: Critically ill patients often display systemic immune dysregulation and increased inflammatory activity. Hemophagocytic lymphohistiocytosis (HLH) represents a rare syndrome defined by the inappropriate survival of cytotoxic T cells and the occurrence of cytokine storms. Although HLH is characterized by relatively high mortality rates, little is known about the predictive value of its diagnostic criteria. Accordingly, our objective was to evaluate these properties within an unselected cohort of critically ill patients admitted to a tertiary intensive care unit (ICU). Methods: This single-center prospective observational study included 176 consecutive patients. Available HLH criteria at admission were assessed, including sCD25 measurements performed using ELISA. Results: Overall, 30-day mortality rates were significantly higher in patients exhibiting two or more criteria of HLH (21.9% vs. 43.3%, p = 0.033). Moreover, sCD25 emerged as an independent risk predictor of 30-day mortality independent of age, sex, the use of vasopressors, and mechanical ventilation (HR 2.72 for the highest tertile vs. lowest tertile, p = 0.012). Additionally, fibrinogen was significantly decreased in non-survivors (p = 0.019), and its addition to the SAPS II score significantly increased its prognostic capability (p = 0.045). In contrast, ferritin and triglyceride levels were not different in survivors versus non-survivors. Conclusions: Critically ill patients displaying two or more HLH criteria exhibit a dramatic increase in 30-day mortality, even in the absence of an established HLH diagnosis. Furthermore, elevated levels of sCD25 and decreased levels of fibrinogen were found to be significant predictors of mortality.Keywords
Funding Information
- Association for the Promotion of Research on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)
- Ludwig Boltzmann Institute for Cardiovascular Research
This publication has 34 references indexed in Scilit:
- Decreased percentages of plasmacytoid dendritic cells predict survival in critically ill patientsJournal of Leukocyte Biology, 2024
- The immunology of sepsisImmunity, 2021
- Analysis of the occurrence of hemophagocytic lymphohistiocytosis (HLH) features in patients with sepsis: a prospective studyScientific Reports, 2021
- The impact of ageing on monocytes and macrophagesImmunology Letters, 2021
- Cytokine StormNew England Journal of Medicine, 2020
- SplenomegalyGastroenterology Clinics of North America, 2018
- Mitochondrial DNA and Toll-Like Receptor-9 Are Associated With Mortality in Critically Ill PatientsCritical Care Medicine, 2015
- Fibrinogen as a key regulator of inflammation in diseaseSeminars in Immunopathology, 2011
- Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: a journey of a thousand miles begins with a single (big) stepBone Marrow Transplantation, 2008
- HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosisPediatric Blood & Cancer, 2006